摘要
背景:微RNA(microRNAs,miRNAs)在癌症中经常被调控,是预测和治疗的重要靶点。除了癌症,miR的生物学功能-149例已在各种疾病中进行了研究。本文旨在总结文献中有关miR-149作为肿瘤治疗分子靶点的报道。 方法:利用Pubmed数据库进行广泛的文献检索,筛选出miR-149在肿瘤发生、癌变过程中的作用及miRNA-碱基的相关文献。d疗法。总共挑选了89份出版物列入这次审查。 结果:根据不同的癌症类型,miR-149可以作为抑癌剂,也可以作为促进肿瘤发生和癌症扩散的“onco-miR”,这表明miRNA具有多种功能。NS。基于miRNA的潜在疗法包括使用miRNA模拟物、miRNA抑制剂、去甲基化剂和环状RNA。 结论:虽然靶向miRNA是一种很有吸引力的抗癌策略,但并不是所有的癌症都可以采用同样的miRNA治疗策略。对miRNA调控机制的全面认识对于改进基于miRNA的治疗方法的设计也是必要的,并且在使用这种方法进行抗癌治疗时需要安全有效的传递方法。
关键词: MIR-149,肿瘤进展,治疗靶点,miRNA模拟物,miRNA抑制剂,表观遗传学。
Current Medicinal Chemistry
Title:miR-149 as a Potential Molecular Target for Cancer
Volume: 25 Issue: 9
关键词: MIR-149,肿瘤进展,治疗靶点,miRNA模拟物,miRNA抑制剂,表观遗传学。
摘要: Background: MicroRNAs (miRNAs) are frequently dysregulated in cancers and serve as attractive targets for prognostication and therapeutic applications. Besides cancer, the biological functions of miR-149 have been studied in various diseases. This review aims to summarize the reports available in the literature, regarding miR-149 as a molecular target for cancer therapeutics.
Methods: An extensive literature search was conducted using the Pubmed database to sieve out articles related to the roles of miR-149 in carcinogenesis and cancer progression, and potential miRNA-based therapies. A total of 89 publications were selected for inclusion in this review.
Results: Depending on the cancer type, miR-149 can behave either as a tumor suppressor or as an ‘onco-miR' that promotes tumorigenesis and cancer spread, suggesting that this miRNA has diverse functions. Potential miRNA-based therapies include the use of miRNA mimics, miRNA inhibitors, demethylating agents and circular RNAs.
Conclusion: Although targeting miRNA is an attractive anti-cancer strategy, not all cancers can be treated by the same miRNA-based strategy. A comprehensive understanding of miRNA regulatory mechanism is also necessary to improve the design of miRNA-based therapeutics and there is a need for safe and efficient delivery methods when using this approach for anti-cancer treatment.
Export Options
About this article
Cite this article as:
miR-149 as a Potential Molecular Target for Cancer, Current Medicinal Chemistry 2018; 25 (9) . https://dx.doi.org/10.2174/0929867324666170718102738
DOI https://dx.doi.org/10.2174/0929867324666170718102738 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Applications of Nanomaterials for Cancer Treatment: Recent Patents Review
Recent Patents on Nanomedicine The Role of Melanocortin Peptides and Receptors in Regulation of Energy Balance
Current Pharmaceutical Design Evolution of the Strategies for Screening and Identifying Human Tumor Antigens
Current Protein & Peptide Science Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma
MicroRNA Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease
Current Alzheimer Research Pro-Oxidant Milieu Blunts Scissors: Insight into Tumor Progression, Drug Resistance, and Novel Druggable Targets
Current Pharmaceutical Design Hepatoma-Derived Growth Factor in Carcinogenesis and Cancer Progression
Current Drug Therapy Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: 'A Hard Days Night'
Current Pharmaceutical Design Inflammation and Chronic Oxidative Stress in Radiation-Induced Late Normal Tissue Injury: Therapeutic Implications
Current Medicinal Chemistry Cachexia and Herbal Medicine: Perspective
Current Pharmaceutical Design Rho as a Target to Promote Repair: Translation to Clinical Studies with Cethrin
Current Pharmaceutical Design Gene Selection in Multi-class Imbalanced Microarray Datasets Using Dynamic Length Particle Swarm Optimization
Current Bioinformatics Prophylactic Admission of an In Vitro Reconstructed Complexes of Human Recombinant Heat Shock Proteins and Melanoma Antigenic Peptides Activates Anti-Melanoma Responses in Mice
Current Molecular Medicine Structure-Activity Relationship Analyses of Glycyrrhetinic Acid Derivatives as Anticancer Agents
Mini-Reviews in Medicinal Chemistry In Vivo Bio-imaging Using Chlorotoxin-based Conjugates
Current Pharmaceutical Design Multitarget-Directed Ligands: Innovative Chemical Probes and Therapeutic Tools Against Alzheimer's Disease
Current Topics in Medicinal Chemistry Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy
Anti-Cancer Agents in Medicinal Chemistry Phosphoinositide 3-Kinases and Leukocyte Migration
Current Immunology Reviews (Discontinued) Targeting the Eph System with Peptides and Peptide Conjugates
Current Drug Targets Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders
Current Drug Metabolism